CRGX250117P10000
- 0.00
- 0.000.00%
CARGO Therapeutics Newsroom
Truist Financial Maintains CARGO Therapeutics(CRGX.US) With Buy Rating
Piper Sandler Maintains CARGO Therapeutics(CRGX.US) With Buy Rating, Maintains Target Price $34
CARGO Therapeutics, Inc. (CRGX) Receives a Buy From Truist Financial
William Blair Maintains CARGO Therapeutics(CRGX.US) With Buy Rating
Cargo Therapeutics Analyst Ratings
William Blair Initiates CARGO Therapeutics(CRGX.US) With Buy Rating
H.C. Wainwright Maintains CARGO Therapeutics(CRGX.US) With Buy Rating, Maintains Target Price $33
Promising Outlook for Cargo Therapeutics: Buy Rating Backed by Strong Financials and Clinical Developments
Truist Financial Maintains CARGO Therapeutics(CRGX.US) With Buy Rating, Maintains Target Price $32
Chardan Capital Maintains CARGO Therapeutics(CRGX.US) With Buy Rating, Maintains Target Price $28
Cargo Therapeutics Analyst Ratings
Chardan Capital Maintains Buy on Cargo Therapeutics, Maintains $28 Price Target
Piper Sandler Maintains CARGO Therapeutics(CRGX.US) With Buy Rating, Maintains Target Price $34
Piper Sandler Maintains CARGO Therapeutics(CRGX.US) With Buy Rating, Maintains Target Price $34
J.P. Morgan Maintains CARGO Therapeutics(CRGX.US) With Buy Rating, Maintains Target Price $30
Piper Sandler Maintains CARGO Therapeutics(CRGX.US) With Buy Rating, Maintains Target Price $34
Truist Financial Maintains CARGO Therapeutics(CRGX.US) With Buy Rating, Maintains Target Price $32
Piper Sandler Maintains CARGO Therapeutics(CRGX.US) With Buy Rating, Cuts Target Price to $34
Cargo Therapeutics Analyst Ratings
Piper Sandler Maintains Overweight on Cargo Therapeutics, Lowers Price Target to $34